These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33740331)

  • 1. [Optimization of dietary support for patients with diabetic nephropathy].
    Sharafetdinov KK; Shekhetov AA; Plotnikova OA; Vorobyeva VM; Vorobyeva IM; Kochetkova AA; Pilipenko VV; Alexeeva RI
    Vopr Pitan; 2021; 90(1):85-93. PubMed ID: 33740331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Specialized products for dietary correction of the diet of patients with non-alcoholic steatohepatitis].
    Vorobyeva VM; Vorobyeva IS; Morozov SV; Sasunova AN; Kochetkova AA; Isakov VA
    Vopr Pitan; 2021; 90(2):100-109. PubMed ID: 34019353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Specialized food products with modified carbohydrate profile for dietary correction of diet of patients with type 2 diabetes].
    Kochetkova AA; Vorobyeva IS; Vorobyeva VM; Sharafetdinov KK; Plotnikova OA; Pilipenko VV; Alexeeva RI; Sasunova AN
    Vopr Pitan; 2018; 87(6):76-88. PubMed ID: 30763493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modern approaches to dietary support for patients with diabetic nephropathy].
    Sharafetdinov KK; Shekhetov AA; Plotnikova OA
    Vopr Pitan; 2018; 87(6):6-15. PubMed ID: 30763485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dietary correction of metabolic disorders in patients with diabetic nephropathy].
    Sharafetdinov KK; Plotnikova OA; Alekseeva RI; Pilipenko VV; Vorobyeva VM
    Vopr Pitan; 2022; 91(5):87-94. PubMed ID: 36394932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soy β-conglycinin retards progression of diabetic nephropathy via modulating the insulin sensitivity and angiotensin-converting enzyme activity in rats fed with high salt diet.
    Yeh WJ; Yang HY; Chen JR
    Food Funct; 2014 Nov; 5(11):2898-904. PubMed ID: 25205218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary flaxseed meal reduces proteinuria and ameliorates nephropathy in an animal model of type II diabetes mellitus.
    Velasquez MT; Bhathena SJ; Ranich T; Schwartz AM; Kardon DE; Ali AA; Haudenschild CC; Hansen CT
    Kidney Int; 2003 Dec; 64(6):2100-7. PubMed ID: 14633132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of specialized product with modified carbohydrate profile on clinical and metabolic parameters in patients with type 2 diabetes].
    Sharafetdinov KK; Plotnikova OA; Nazarova AM; Kondratyeva OV; Frolova YV; Kochetkova AA; Vorobyeva VM
    Vopr Pitan; 2019; 88(4):88-94. PubMed ID: 31722146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Theoretical and practical aspects of development of biscuits with a modified carbohydrate profile for patients with type 2 diabetes].
    Kochetkova AA; Vorobyova VM; Vorobyova IS; Sharafetdinov KK; Sarkisyan VA; Semin MO; Savenkova TV; Soldatova EA; Osipov MV
    Vopr Pitan; 2015; 84(6):122-31. PubMed ID: 29378107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Inflammatory and Antioxidative Properties of Isoflavones Provide Renal Protective Effects Distinct from Those of Dietary Soy Proteins against Diabetic Nephropathy.
    Jheng HF; Hayashi K; Matsumura Y; Kawada T; Seno S; Matsuda H; Inoue K; Nomura W; Takahashi H; Goto T
    Mol Nutr Food Res; 2020 May; 64(10):e2000015. PubMed ID: 32281228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dietary fiber and carbohydrate on glucose and lipoprotein metabolism in diabetic patients.
    Riccardi G; Rivellese AA
    Diabetes Care; 1991 Dec; 14(12):1115-25. PubMed ID: 1663443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Dietary Antioxidants on Oxidative Stress in Diabetic Nephropathy.
    Gerardo Yanowsky-Escatell F; Andrade-Sierra J; Pazarín-Villaseñor L; Santana-Arciniega C; De Jesús Torres-Vázquez E; Samuel Chávez-Iñiguez J; Ángel Zambrano-Velarde M; Martín Preciado-Figueroa F
    Iran J Kidney Dis; 2020 Mar; 14(2):81-94. PubMed ID: 32165592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New breeding and technological evaluation criteria for fruit and berry products for the healthy and dietary food industry].
    Akimov MY
    Vopr Pitan; 2020; 89(4):244-254. PubMed ID: 32986337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypolipidemic and Antioxidant Properties of Oryzanol Concentrate in Reducing Diabetic Nephropathy via SREBP1 Downregulation Rather than β-Oxidation.
    G B; V G; T S; A S MK; C HK; G SK
    Mol Nutr Food Res; 2018 Apr; 62(8):e1700511. PubMed ID: 29469229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary n-3 polyunsaturated fatty acids revert renal responses induced by a combination of 2 protocols that increase the amounts of advanced glycation end product in rats.
    de Assis AM; Rech A; Longoni A; da Silva Morrone M; de Bittencourt Pasquali MA; Perry ML; Souza DO; Moreira JC
    Nutr Res; 2015 Jun; 35(6):512-22. PubMed ID: 25963123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modern approaches to the development of gluten-free bakery formulations].
    Zaytseva LV; Yudina TA; Ruban NV; Bessonov VV; Mekhtiev VS
    Vopr Pitan; 2020; 89(1):77-85. PubMed ID: 32083828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of dietary lipids in diabetic nephropathy].
    Almeida JC; Mello VD; Canani LH; Gross JL; Azevedo MJ
    Arq Bras Endocrinol Metabol; 2009 Jul; 53(5):634-45. PubMed ID: 19768254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary approaches to stop hypertension, mediterranean dietary pattern, and diabetic nephropathy in women with type 2 diabetes: A case-control study.
    Jayedi A; Mirzaei K; Rashidy-Pour A; Yekaninejad MS; Zargar MS; Akbari Eidgahi MR
    Clin Nutr ESPEN; 2019 Oct; 33():164-170. PubMed ID: 31451255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-O-methylhonokiol ameliorates type 2 diabetes-induced nephropathy in mice likely by activation of AMPK-mediated fatty acid oxidation and Nrf2-mediated anti-oxidative stress.
    Ma T; Zheng Z; Guo H; Lian X; Rane MJ; Cai L; Kim KS; Kim KT; Zhang Z; Bi L
    Toxicol Appl Pharmacol; 2019 May; 370():93-105. PubMed ID: 30876865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liraglutide attenuates renal tubular ectopic lipid deposition in rats with diabetic nephropathy by inhibiting lipid synthesis and promoting lipolysis.
    Su K; Yi B; Yao BQ; Xia T; Yang YF; Zhang ZH; Chen C
    Pharmacol Res; 2020 Jun; 156():104778. PubMed ID: 32247822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.